ACM
IRWD icon

AlphaCrest Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

AlphaCrest Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-306,494
Closed -$3.17M – 575
2022
Q3 		$3.17M Buy
306,494
+130,780
+74% +$1.48M 0.19% 84
2022
Q2 		$2.03M Buy
175,714
+143,071
+438% +$1.69M 0.1% 308
2022
Q1 		$411K Sell
32,643
-243,323
-88% -$2.79M 0.02% 987
2021
Q4 		$3.22M Buy
275,966
+136,387
+98% +$1.67M 0.12% 205
2021
Q3 		$1.82M Buy
139,579
+8,834
+7% +$114K 0.09% 351
2021
Q2 		$1.68M Buy
130,745
+17,353
+15% +$199K 0.07% 424
2021
Q1 		$1.27M Buy
113,392
+59,497
+110% +$629K 0.07% 404
2020
Q4 		$614K Sell
53,895
-7,842
-13% -$85.8K 0.05% 538
2020
Q3 		$555K Sell
61,737
-846
-1% -$8.41K 0.06% 530
2020
Q2 		$646K Buy
62,583
+8,095
+15% +$82.9K 0.11% 281
2020
Q1 		$550K Buy
54,488
+43,013
+375% +$506K 0.07% 524
2019
Q4 		$153K Sell
11,475
-12,925
-53% -$143K 0.01% 1225
2019
Q3 		$209K Buy
+24,400
New +$237K 0.01% 1204
2019
Q2 		– Sell
-28,656
Closed -$325K – 1080
2019
Q1 		$325K Buy
+28,656
New +$320K 0.05% 625

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AlphaCrest Capital Management's IRWD Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2022, closing a stake of 306,494 shares — an estimated $3.17M sold.

AlphaCrest Capital Management first reported a position in IRWD in Q1 2019 and held it in 14 quarters. The position peaked at $3.22M in Q4 2021. 250 funds tracked by Wall St. Rank hold IRWD as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 306,494 Ironwood Pharmaceuticals shares in Q4 2022, an estimated $3.17M.
  • AlphaCrest Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2019 and held it in 14 quarters.
  • AlphaCrest Capital Management's Ironwood Pharmaceuticals position peaked at $3.22M in Q4 2021.
  • 250 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.